To determine if topical nonsteroidal anti-inflammatory drug (NSAID) use after Descemet stripping automated endothelial keratoplasty (DSAEK) is associated with the development of interface haze.
Methods:
A retrospective case–control study of patients undergoing DSAEK surgery.
Results:
Of the 61 patients receiving topical NSAIDs, 51% were noted to develop interface haze, and 9% of the control group (N=100, no NSAID) developed haze. There was no significant difference in best corrected visual acuity between the 2 groups.
Conclusions:
Topical NSAID use is associated with the development of interface haze, although it may not be visually significant and could be related to confounding factors.
Get full access to this article
View all access options for this article.
References
1.
NieuwendaalC.P., Lapid-GortzakR., van der MeulenI.J., MellesG.J.Posterior lamellar keratoplasty using descemetorhexis and organ-cultured donor corneal tissue (Melles technique)Cornea, 25:933–936. 2006.
LeeW.B., JacobsD.S., MuschD.C.et al.Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology, 116:1818–1830. 2009.
4.
ShihC.Y., RitterbandD.C., RubinoS.et al.Visually significant and nonsignificant complications arising from Descemet stripping automated endothelial keratoplasty. Am. J. Ophthalmol., 148:837–843. 2009.
5.
SuhL.H., YooS.H., DeobhaktaA.et al.Complications of Descemet's stripping with automated endothelial keratoplasty: survey of 118 eyes at one institute. Ophthalmology, 115:1517–1524. 2008.
6.
LetkoE., PriceD.A., LindosoE.M., PriceM.O., PriceF.W.Jr.Secondary graft failure and repeat endothelial keratoplasty after Descemet's stripping automated endothelial keratoplasty. Ophthalmology, 118:310–314. 2011.
7.
EspanaE.M., HuangB.Confocal microscopy study of donor-recipient interface after Descemet's stripping with endothelial keratoplasty. Br. J. Ophthalmol., 94:903–908. 2010.
SuhL.H., DawsonD.G., MutapcicL., RosenfeldS.I., CulbertsonW.W., YooS.H., O'BrienT.P., DubovyS.R.Histopathologic examination of failed grafts in descemet's stripping with automated endothelial keratoplasty. Ophthalmology, 116:603–608. 2009.
14.
TrattlerW., McDonaldM.Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Cornea, 26:665–669. 2007.
15.
ReviglioV.E., RanaT.S., LiQ.J., AshrafM.F., DalyM.K., O'BrienT.P.Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea. J. Cataract Refract. Surg., 29:989–997. 2003.
16.
CarverA.A., ChenG.W., StoneD.U.Risk Factors for Graft Dislocation Following Descemet's Stripping Endothelial Keratoplasty. Clin. Surg. Ophthalmol., 29:228–234. 2011.
17.
CaldwellM.C., AfshariN.A., DecroosF.C., ProiaA.D.The histology of graft adhesion in descemet stripping with endothelial keratoplasty. Am. J. Ophthalmol., 148:277–281. 2009.
18.
StojanovicA., NitterT.A.Correlation between ultraviolet radiation level and the incidence of late-onset corneal haze after photorefractive keratectomy. J. Cataract Refract. Surg., 27:404–410. 2001.
19.
ReviglioV.E., HakimM.A., SongJ.K., O'BrienT.P.Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC Ophthalmol., 6,3:10. 2003.
20.
HayesS., CafaroT.A., BoguslawskaP.J., Kamma-LorgerC.S., BooteC., HarrisJ., YoungR., HillerJ., TerrillN., MeekK.M., SerraH.M.The effect of vitamin C deficiency and chronic ultraviolet-B exposure on corneal ultrastructure: a preliminary investigation. Mol. Vis., 17:3107–3115. 2011.
